Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Proto Labs (PRLB) Q3 2024 Earnings Call Transcript
Motley Fool Transcribing
|
Nov 1, 2024
PRLB earnings call for the period ending September 30, 2024.
Why Proto Labs Stock Soared 34% After Earnings
Rich Smith
|
Nov 1, 2024
At a valuation of just 10 times FCF, Proto Labs stock could be a bargain.
Is Madrigal Pharmaceuticals Stock a Buy?
Prosper Junior Bakiny
|
Aug 17, 2024
The biotech could be worth a lot more in 10 years.
This 1 Setback for Novo Nordisk Is Bullish for Madrigal Pharmaceuticals Stock
Alex Carchidi
|
Aug 14, 2024
One player's minor pain is another's moderate gain.
Is It Too Late to Buy Madrigal Pharmaceuticals Stock?
Alex Carchidi
|
Aug 5, 2024
Will being the first to its market ensure that its future is bright?
Proto Labs (PRLB) Q2 2024 Earnings Call Transcript
Motley Fool Transcribing
|
Aug 2, 2024
PRLB earnings call for the period ending June 30, 2024.
Is Madrigal Pharmaceuticals a Millionaire Maker?
Alex Carchidi
|
Jun 30, 2024
Its revenue ramp-up is just starting, and its market looks lucrative.
Is Madrigal Pharmaceuticals Stock a Buy?
Prosper Junior Bakiny
|
Jun 28, 2024
The company could become a prominent player in the biotech industry, but that might take a while.
Thinking of Buying Madrigal Pharmaceuticals Stock? Eli Lilly Would Like to Have a Word.
Alex Carchidi
|
Jun 16, 2024
Eli Lilly just drizzled on Madrigal Pharmaceuticals' parade.
Where Will Madrigal Pharmaceuticals Be in 3 Years?
Alex Carchidi
|
Jun 15, 2024
The coast is clear for it to grow, for now.
View More Articles